FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--The latest findings from the ReGen Biologics CMI™ MultiCenter Clinical Trial were presented recently in Berlin, Germany. The data were presented by Richard Steadman, M.D. at the Joint German Congress of Orthopaedics and Trauma Surgery meeting, the largest orthopedic congress in Europe, with over 6700 attendants in 2006.
